1. Home
  2. EML vs MOLN Comparison

EML vs MOLN Comparison

Compare EML & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Company (The)

EML

Eastern Company (The)

N/A

Current Price

$26.19

Market Cap

142.3M

ML Signal

N/A

Logo Molecular Partners AG

MOLN

Molecular Partners AG

N/A

Current Price

$3.22

Market Cap

137.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EML
MOLN
Founded
1858
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
142.3M
137.2M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
EML
MOLN
Price
$26.19
$3.22
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $10.22
AVG Volume (30 Days)
★ 7.8K
2.1K
Earning Date
11-10-2026
10-29-2026
Dividend Yield
★ 1.62%
N/A
EPS Growth
★ 185.40
N/A
EPS
★ 1.04
N/A
Revenue
★ $248,970,345.00
N/A
Revenue This Year
$19.05
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$27.70
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$17.61
$3.09
52 Week High
$29.91
$5.36

Technical Indicators

Market Signals
Indicator
EML
MOLN
Relative Strength Index (RSI) 51.97 35.97
Support Level $24.02 N/A
Resistance Level $26.58 $4.21
Average True Range (ATR) 1.64 0.12
MACD 0.20 -0.04
Stochastic Oscillator 43.94 17.36

Price Performance

Historical Comparison
EML
MOLN

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Share on Social Networks: